Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00140452
Status:
COMPLETED
Last Update Posted:
2007-11-21
First Post:
2005-08-31
Brief Title:
Phase II Study Using Thalidomide for the Treatment of ALS
Sponsor:
Dartmouth-Hitchcock Medical Center
Organization:
Dartmouth-Hitchcock Medical Center
Organization Data
Organization:
Dartmouth-Hitchcock Medical Center
Class:
OTHER
Study ID:
ALS-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celgene Corporation | INDUSTRY |